Has Thomas Dahlberg, DO received payments from drug or device companies?

Yes. Drug and device makers reported $217,705 in general payments to Thomas Dahlberg, DO across 878 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Dahlberg, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Dahlberg, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Dahlberg, DO

Pain Medicine · Rockford, ILNPI 1801856380

Payments from drug & device makers

$217,705in general payments, 2019–2025

Across 878 payments — averaging $247.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$168K
Vertex$18K
Boston Scientific$7K
Abbott$6K
Trevena, Inc.$5K
Globus Medical$3K
plus $11K from 44 others

What the payments were for

Consulting fees$40,75319%
Speaking & faculty fees$118,87055%
Travel & lodging$36,77417%
Food & beverage$21,30910%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	316	$168,082
Vertex	24	$18,008
Boston Scientific	26	$7,072
Abbott	60	$6,249
Trevena, Inc.	11	$4,751
Globus Medical	12	$2,818
Saluda Medical Americas, Inc.	20	$2,653
AbbVie(2 entities)	54	$1,140
Biotronik NRO, Inc.	37	$1,060
Collegium Pharmaceutical, Inc.	61	$1,016
Pfizer	45	$569
Amgen(2 entities)	22	$495
Medtronic	14	$418
Biodelivery Sciences International, Inc.	27	$356
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	20	$337
Fidia Pharma USA Inc.	15	$288
Pacira Pharmaceuticals Incorporated	5	$241
Almatica Pharma LLC	12	$204
Avanos Medical	8	$196
Tersera Therapeutics LLC	10	$182
Biohaven Pharmaceutical Holding Company Ltd.	9	$157
SPR Therapeutics, Inc	3	$147
Vertos Medical, Inc.	2	$129
Johnson & Johnson	5	$100
Pacira Therapeutics, Inc.	6	$86
Nalu Medical, Inc.	3	$73
Teva Pharmaceuticals USA, Inc.	5	$72
Stryker	3	$69
Lilly USA, LLC	4	$68
Si-bone, Inc.	2	$64
Scilex Pharmaceuticals Inc.	3	$63
Biohaven Pharmaceuticals, Inc.	4	$59
Takeda Pharmaceuticals U.S.A., Inc.	5	$50
Daiichi Sankyo Inc.	3	$48
Kowa Pharmaceuticals America, Inc.	3	$43
Lundbeck LLC	2	$42
Sanofi-aventis U.S. LLC	2	$36
Relievant Medsystems, Inc.	2	$32
Shionogi Inc	2	$29
Averitas Pharma Inc.	1	$26
Spinal Simplicity, LLC	1	$25
Valinor Pharma, LLC	1	$23
Impel Pharmaceuticals Inc.	1	$20
AstraZeneca	1	$17
Xeris Pharmaceuticals, Inc.	1	$17
Curonix LLC	1	$17
Stimwave Technologies Incorporated	1	$16
Vibrant Gastro, Inc.	1	$16
Athena Bioscience, LLC	1	$12
GRT US Holding, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Omnia$68,357
Senza Spinal Cord Stimulation System$55,163
Senza$42,218
JOURNAVX$17,706
GENERAL PAIN MANAGEMENT$6,255
PROCLAIM$4,722
Olinvyk$4,578
Evoke$2,215
Prospera$270
ETERNA$262
INTELLIS ADAPTIVESTIM$146
BIOTRONIK$146
Iovera$125
QULIPTA$125
UBRELVY$125
Proclaim IPG$114
Intracept RF Probe$105

How this compares

$217,705 in reported general payments places this provider in the 95th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois →

Medicare billing

Part B allowed, 2024

$751,575

Medicare patients

772

Services billed

16,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	265	$4,076
Fentanyl	41	$3,757
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	154	$3,715
Pregabalin	83	$1,863
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	24	$1,025
Celecoxib	56	$703
Morphine Sulfate ErMorphine Sulfate	24	$682
Oxycodone Hcl	13	$519
Tramadol Hcl	95	$466
Methylprednisolone	92	$353
Cyclobenzaprine Hcl	50	$336
Cephalexin	59	$263
Meloxicam	116	$247
Duloxetine Hcl	13	$234
Acetaminophen-CodeineAcetaminophen With Codeine	12	$230

Paid to pharmacies, not to this prescriber.

Other pain medicine in Rockford

Frederick GahlRockford$12K
Zachary BelfordRockford$11K
Ricardo VallejoBloomington$3.1M
David DickersonEvanston$766K
Albert SinghQuincy$357K
Steven CohenChicago$292K
Nirav ShahSkokie$137K
Ryan KutaNaperville$114K
Anthony LebarioElgin$87K
Keith SchmidtHoffman Estates$81K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →